Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.
Biostatistics Task Force of Taichung Veterans General Hospital, Taichung, Taiwan.
J Microbiol Immunol Infect. 2021 Jun;54(3):474-481. doi: 10.1016/j.jmii.2020.01.001. Epub 2020 Jan 24.
High serum IgE level in atopic children usually implies a highly sensitized condition. However, there is a subgroup of atopic children for whom a specific allergen cannot be identified. In this study, we analyzed follow-up data from these children.
From March 2014 to July 2017, we recruited 14 atopic children with serum total IgE level higher than 500 Ku/L, but with no specific allergen identified by repeated MAST tests initially. Follow-up studies of specific IgE were conducted by the OPTIGEN MAST Allergy test and ImmunoCAP assays (Thermo Fisher Scientific/Phadia), while total IgE and specific IgG were measured by ImmunoCAP.
The patients were aged from 2 to 17 y/o. The follow-up MAST tests showed significantly positive results in 10 patients. There were no significant differences in any of the clinical characteristics between the MAST-positive and MAST-negative groups. In the MAST-negative group, five allergen-specific IgE antibodies, including those for cockroach, Euroglyphus maynei, Blomia tropicalis, shrimp, and crab, were strongly predictive of negative ImmunoCAP results, according to ROC (Receiver operating characteristic curve) analysis of the AUC (Area under the Curve of ROC) (0.70-0.95), with significance set at p < 0.05.
In two thirds of atopic children with a high serum IgE whose specific allergen had yet to be identified, it was possible to identify the specific MAST allergen(s) after an average follow-up of 33.2 months. For patients who still had negative results in follow-up MAST, mite DP, DF, and DM may be suitable choices for further allergen identification by ImmunoCAP.
特应性儿童的血清 IgE 水平升高通常意味着高度致敏状态。然而,有一部分特应性儿童无法确定特定的过敏原。在本研究中,我们分析了这些儿童的随访数据。
从 2014 年 3 月至 2017 年 7 月,我们招募了 14 名血清总 IgE 水平高于 500 Ku/L 的特应性儿童,但最初通过重复 MAST 试验未能确定特定的过敏原。采用 OPTIGEN MAST 过敏试验和 ImmunoCAP 测定(赛默飞世尔科技/Phadia)进行特异性 IgE 的随访研究,同时采用 ImmunoCAP 测定总 IgE 和特异性 IgG。
患者年龄为 2 至 17 岁。随访 MAST 试验显示 10 例患者结果明显阳性。MAST 阳性组和 MAST 阴性组之间的任何临床特征均无显著差异。在 MAST 阴性组中,根据 ROC(Receiver operating characteristic curve)分析 AUC(ROC 曲线下面积)(0.70-0.95),五种过敏原特异性 IgE 抗体,包括蟑螂、Euroglyphus maynei、Blomia tropicalis、虾和蟹,对于预测 ImmunoCAP 结果阴性具有很强的预测性,具有统计学意义(p < 0.05)。
在三分之二的特应性儿童中,血清 IgE 水平升高,且特定过敏原尚未确定,在平均随访 33.2 个月后,可能会确定特定的 MAST 过敏原。对于随访 MAST 仍为阴性的患者,尘螨 DP、DF 和 DM 可能是通过 ImmunoCAP 进一步鉴定过敏原的合适选择。